Endovascular therapy and medical management of large-core infarcts: prognostic determinants in a retrospective cohort

大核心梗死的血管内治疗和药物治疗:回顾性队列研究中的预后决定因素

阅读:2

Abstract

INTRODUCTION: To investigate the independent prognostic risk factors in acute ischemic stroke patients with large-core infarcts, including patients beyond standard eligibility thresholds for core volume or ASPECTS and provide evidence for early clinical intervention. METHODS: This retrospective cohort study analyzed the clinical data of 96 consecutive patients with large-core infarcts admitted to a regional stroke center between June 2020 and June 2024. Participants were stratified into poor outcome [modified Rankin Scale (mRS) 4-6] and favorable outcome (mRS 0-3) groups based on the 90-day post-intervention assessments. Comparative analyses of the baseline demographics, biochemical parameters, neuroimaging metrics, and treatment modalities were conducted. Univariate analysis followed by multivariate logistic regression was used to identify independent predictors of favorable outcome. A prespecified EVT subgroup analysis was performed, including procedural variables (onset-to-puncture time, puncture-to-recanalization time) and clinical variables in multivariate regression. RESULTS: Among the 96 patients, 17 (17.7%) achieved favorable outcomes (mRS 0-3) and 79 (82.3%) had poor outcomes (mRS 4-6). Multivariable analysis identified four independent predictors of poor outcome: non-receipt of EVT [OR = 10.22, 95% confidence interval (CI): 1.05-99.76], hyperglycemia (per 1 mmol/L; OR = 1.76, 95% CI: 1.10-2.82), and higher platelet count (per 10(3)/μL; OR = 1.02, 95% CI: 1.00-1.03) (all p < 0.05). In the EVT subgroup (n = 62), hyperglycemia remained significantly associated with poor outcomes (OR = 1.70, 95% CI: 1.04-2.78, p = 0.034). CONCLUSION: EVT significantly improves functional outcomes in large-core infarcts. Preoperative hyperglycemia and elevated platelet count are independent predictors of poor outcomes. These findings support standardized protocols that integrate early EVT with glycemic control and coagulation monitoring in this patient population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。